Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (23 quarters reported)
$268M in Q4 2020 → $47.5M now. Hover for any quarter.
As reported for the quarter ended June 30, 2026. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| RM Royce Micro-cap Tr Inc | 8.6% | Added 14% | 278,051 | $4.07M |
| AG Asa Gold And Precious Mtls L | 7.7% | Added 35% | 70,390 | $3.66M |
| Royce Small Cap Trust Inc | 7.5% | Unchanged | 192,509 | $3.56M |
| NN Neuberger Next Generation | 7.1% | Unchanged | 204,562 | $3.38M |
| PD Pimco Dynamic Income Strateg | 6.9% | Unchanged | 157,700 | $3.28M |
| GA General Amern Invs Co Inc | 6.5% | Unchanged | 48,755 | $3.11M |
| PC Pimco Calif Mun Income Fd | 6.3% | Unchanged | 333,093 | $2.99M |
| TC Tri Contl Corp | 6.3% | Added 9.6% | 86,458 | $2.98M |
| NS Nuveen S&P 500 Dynamic Overw | 6.2% | Unchanged | 157,395 | $2.93M |
| CG Calamos Gbl Dyn Income Fund | 6.2% | Unchanged | 328,901 | $2.93M |
| BM Bny Mellon Strategic Muns In | 6.0% | Unchanged | 438,676 | $2.83M |
| MF Mexico Fd Inc | 5.9% | Unchanged | 128,185 | $2.8M |
| HO Highland Opps & Income Fd | 4.8% | Added 14% | 317,055 | $2.26M |
| AN Alliancebernstein Natl Mun I | 4.2% | Trimmed 21% | 175,187 | $2M |
| MS Morgan Stanley India Invt Fd | 3.8% | Unchanged | 79,031 | $1.8M |
| JS Japan Smaller Capitalization | 3.7% | Unchanged | 150,412 | $1.77M |
| DM Destra Multi-alternative Fd | 0.9% | Unchanged | 54,723 | $409K |
| NG New Germany Fd Inc | 0.8% | Added 33% | 33,098 | $379K |
| Endra Life Sciences Inc | 0.7% | Added 14% | 59,272 | $316K |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.
quarter ended June 30, 2026 · filed August 12, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AG Asa Gold And Precious Mtls L | Added | +18,171 | +$946K | 7.7% |
| AN Alliancebernstein Natl Mun I | Trimmed | −47,077 | −$537K | 4.2% |
| RM Royce Micro-cap Tr Inc | Added | +35,001 | +$512K | 8.6% |
| HO Highland Opps & Income Fd | Added | +39,987 | +$285K | 4.8% |
| TC Tri Contl Corp | Added | +7,538 | +$259K | 6.3% |
| NG New Germany Fd Inc | Added | +8,178 | +$93.7K | 0.8% |
| Endra Life Sciences Inc | Added | +7,372 | +$39.3K | 0.7% |
quarter ended March 31, 2026 · filed May 01, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| NS Nuveen S&P 500 Dynamic Overw | New | +157,395 | +$2.53M | 6.0% |
| RM Royce Micro-cap Tr Inc | Added | +155,972 | +$1.76M | 6.5% |
| MF Mexico Fd Inc | Added | +79,898 | +$1.67M | 6.4% |
| GA General Amern Invs Co Inc | Added | +27,910 | +$1.63M | 6.8% |
| CG Calamos Gbl Dyn Income Fund | Added | +197,098 | +$1.43M | 5.7% |
| AN Alliancebernstein Natl Mun I | Added | +125,415 | +$1.34M | 5.7% |
| TC Tri Contl Corp | Added | +38,469 | +$1.22M | 5.9% |
| JS Japan Smaller Capitalization | Added | +110,637 | +$1.21M | 3.9% |
| BM Bny Mellon Strategic Muns In | Added | +176,624 | +$1.11M | 6.6% |
| MS Morgan Stanley India Invt Fd | Added | +49,821 | +$1.03M | 3.9% |
Showing the 10 largest of 17 changes.
quarter ended December 31, 2025 · filed February 06, 2026
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| AG Asa Gold And Precious Mtls L | New | +52,219 | +$3.12M | 12.3% |
| Royce Small Cap Trust Inc | New | +192,509 | +$3.1M | 12.3% |
| PD Pimco Dynamic Income Strateg | New | +151,007 | +$2.84M | 11.2% |
| NN Neuberger Next Generation | New | +169,873 | +$2.45M | 9.7% |
| PC Pimco Calif Mun Income Fd | New | +259,092 | +$2.26M | 8.9% |
| BM Bny Mellon Strategic Muns In | New | +262,052 | +$1.67M | 6.6% |
| TC Tri Contl Corp | New | +40,451 | +$1.32M | 5.2% |
| GA General Amern Invs Co Inc | New | +20,845 | +$1.22M | 4.8% |
| AN Alliancebernstein Natl Mun I | New | +96,849 | +$1.05M | 4.1% |
| CG Calamos Gbl Dyn Income Fund | New | +131,803 | +$977K | 3.9% |
Showing the 10 largest of 19 changes.
quarter ended September 30, 2025 · filed November 04, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| PT Plus Therapeutics Inc | New | +918,914 | +$628K | 100.0% |
| N None | Exited | +0 | — | — |
quarter ended June 30, 2025 · filed August 07, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Zevra Therapeutics Inc | Exited | −1,287,333 | −$9.64M | — |
| Alnylam Pharmaceuticals Inc | Exited | −25,000 | −$6.75M | — |
| Evolus Inc | Exited | −296,193 | −$3.56M | — |
| XM Xtant Med Hldgs Inc | Exited | −7,252,998 | −$3.41M | — |
| Avadel Pharmaceuticals PLC | Exited | −419,131 | −$3.28M | — |
| Contineum Therapeutics Inc | Exited | −303,857 | −$2.12M | — |
| PM Profound Med Corp | Exited | −360,589 | −$2.1M | — |
| Xenon Pharmaceuticals Inc | Exited | −60,251 | −$2.02M | — |
| Essa Pharma Inc | Exited | −1,050,369 | −$1.66M | — |
| Skye Bioscience Inc | Exited | −904,865 | −$1.44M | — |
Showing the 10 largest of 25 changes.
quarter ended March 31, 2025 · filed May 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Adma Biologics Inc | Exited | −1,395,000 | −$23.9M | — |
| Vera Therapeutics Inc | Exited | −432,000 | −$18.3M | — |
| Sarepta Therapeutics Inc | Exited | −127,000 | −$15.4M | — |
| EL Establishment Labs Hldgs Inc | Exited | −305,000 | −$14.1M | — |
| EL Establishment Labs Hldgs Inc | Exited | −300,000 | −$13.8M | — |
| SR Scholar Rock Hldg Corp | Exited | −300,000 | −$13M | — |
| Edwards Lifesciences Corp | Exited | −165,000 | −$12.2M | — |
| Soleno Therapeutics Inc | Exited | −250,000 | −$11.2M | — |
| Capricor Therapeutics Inc | Exited | −714,000 | −$9.85M | — |
| Rxsight Inc | Exited | −285,000 | −$9.8M | — |
Showing the 10 largest of 72 changes.
quarter ended December 31, 2024 · filed February 13, 2025
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| EL Establishment Labs Hldgs Inc | New | +300,000 | +$13.8M | 3.9% |
| SR Scholar Rock Hldg Corp | New | +300,000 | +$13M | 3.7% |
| Vera Therapeutics Inc | Trimmed | −252,000 | −$10.7M | 5.2% |
| Vaxcyte Inc | Exited | −72,000 | −$8.23M | — |
| EL Establishment Labs Hldgs Inc | Added | +174,000 | +$8.02M | 4.0% |
| IT Intra-cellular Therapies Inc | Trimmed | −79,000 | −$6.6M | 1.8% |
| Biohaven Ltd | Added | +175,000 | +$6.54M | 2.6% |
| IT Irhythm Technologies Inc | Exited | −86,000 | −$6.38M | — |
| Argenx Se | New | +10,000 | +$6.15M | 1.7% |
| Rxsight Inc | Added | +173,000 | +$5.95M | 2.8% |
Showing the 10 largest of 92 changes.
quarter ended September 30, 2024 · filed November 14, 2024
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Edwards Lifesciences Corp | New | +222,000 | +$14.6M | 4.3% |
| Alimera Sciences Inc | Exited | −2,150,000 | −$12M | — |
| Sarepta Therapeutics Inc | Added | +88,100 | +$11M | 6.2% |
| Glaukos Corp | New | +77,000 | +$10M | 3.0% |
| Argenx Se | Exited | −23,000 | −$9.89M | — |
| MM Merit Med Sys Inc | New | +85,000 | +$8.4M | 2.5% |
| Vaxcyte Inc | New | +72,000 | +$8.23M | 2.4% |
| AP Arrowhead Pharmaceuticals In | New | +355,000 | +$6.88M | 2.0% |
| Ascendis Pharma A/s | Exited | −50,000 | −$6.82M | — |
| IT Irhythm Technologies Inc | New | +86,000 | +$6.38M | 1.9% |
Showing the 10 largest of 74 changes.
Loading...
